Safilo Group S.p.A. (LON:0NJ5)
1.286
0.00 (0.00%)
Jul 19, 2022, 4:45 PM BST
Safilo Group Revenue
Safilo Group had revenue of 537.63M EUR in the half year ending June 30, 2025, a decrease of -2.27%. This brings the company's revenue in the last twelve months to 998.89M, down -0.76% year-over-year. In the year 2024, Safilo Group had annual revenue of 993.22M, down -3.08%.
Revenue (ttm)
998.89M EUR
Revenue Growth
-0.76%
P/S Ratio
0.80
Revenue / Employee
274.04K EUR
Employees
3,645
Market Cap
681.46M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 993.22M | -31.51M | -3.08% |
| Dec 31, 2023 | 1.02B | -52.01M | -4.83% |
| Dec 31, 2022 | 1.08B | 107.16M | 11.05% |
| Dec 31, 2021 | 969.58M | 189.29M | 24.26% |
| Dec 31, 2020 | 780.30M | -158.74M | -16.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |